Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

GSK to seek dismissal of Zantac Florida case as court rejects testimony

(Sharecast News) - UK pharma giant GSK has welcomed a US court ruling excluding expert testimony in the long-running Zantac lawsuit where the plaintiffs allege the heartburn drug caused cancer and said it would now ask for the case to be dismissed. GSK said it would now seek dismissal of the upcoming Wilson case in the Florida State Court where the plaintiffs "alleged a causal link between ranitidine and prostate cancer".

In 2020, the US Food and Drug Administration (FDA) asked drugmakers to pull Zantac, also known as ranitidine, off the market over concerns it could turn into a cancer-causing chemical when exposed to heat.

The company this week won a case, breaking a run of settlement with claimants. GSK and other firms who have distributed the drug, Pfizer and Sanofi, face lawsuits from thousands of people with cancer related claims.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

MicroSalt makes progress in expanding patent portfolio
(Sharecast News) - MicroSalt, which develops and supplies low-sodium, full-flavour salt, announced significant progress in expanding its global patent portfolio on Friday.
CMA accepts undertakings, clears Barratt acquisition of Redrow
(Sharecast News) - Barratt Developments announced on Friday that the UK Competition and Markets Authority (CMA) had cleared its acquisition of Redrow, following a consultation on undertakings offered by both companies.
Anglo-Eastern takes full ownership of two Indonesian subsidiaries
(Sharecast News) - Anglo-Eastern Plantations announced on Friday that it has completed the acquisition of the remaining minority stakes in two of its Indonesian subsidiaries, further consolidating its ownership in the region.
Zigup CFO Philip Vincent resigns
(Sharecast News) - Zigup said on Friday that chief financial officer Philip Vincent has resigned to take on the same role at another business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.